Endothelial dysfunction in an ovine model of collagen-induced arthritis

Journal of Vascular Research

Volumn 51, Issue 2, 2014, Pages 90-101

  Dooley, Laura M ^a   Washington, Elizabeth A ^a   Abdalmula, Anwar ^a   Tudor, Elizabeth M ^a   Kimpton, Wayne G ^a   Bailey, Simon R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Coronary artery; Endothelium; Nitric oxide; Rheumatoid arthritis; Vasodilation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BRADYKININ; CARBACHOL; GUANINE NUCLEOTIDE BINDING PROTEIN; NITROPRUSSIDE SODIUM; SEROTONIN; VASODILATOR AGENT; 15 HYDROXY 9ALPHA,11ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE; G PROTEIN COUPLED RECEPTOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTHRITIS; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORONARY ARTERY; DIGITAL ARTERY; ENDOTHELIAL DYSFUNCTION; FEMALE; LEISURE; NONHUMAN; PRIORITY JOURNAL; SHEEP DISEASE; SIGNAL TRANSDUCTION; CARDIOVASCULAR RISK; CONCENTRATION RESPONSE; EC50; EWE; OVINE MODEL; RHEUMATOID ARTHRITIS; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EXTREMITIES; FEMALE; SHEEP; VASODILATION; VASODILATOR AGENTS;

EID: 84895579824     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000358367     Document Type: Article

References (55)

1. Kitas GD, Gabriel SE: Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 2011; 70: 8-14.
2. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA: The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-494.
3. Bergholm R, Leirisalo-Repo M, Vehkavaara S, Makimattila S, Taskinen MR, Yki-Jarvinen H: Impaired responsiveness to no in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 2002; 22: 1637-1641.
4. Vaudo G, Marchesi S, Gerli R, Allegrucci R, Giordano A, Siepi D, Pirro M, Shoenfeld Y, Schillaci G, Mannarino E: Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004; 63: 31-35.
5. Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, Muszbek L, Csipo I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomjak E, Veres K, Szegedi G, Shoenfeld Y, Soltesz P: Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 2008; 35: 398-406.
6. Lerman A, Zeiher AM: Endothelial function: cardiac events. Circulation 2005; 111: 363-368.
7. Haruna Y, Morita Y, Komai N, Yada T, Sakuta T, Tomita N, Fox DA, Kashihara N: Endothelial dysfunction in rat adjuvant-induced arthritis - vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase. Arthritis Rheum 2006; 54: 1847-1855.
8. Prati C, Berthelot A, Wendling D, Demougeot C: Endothelial dysfunction in rat adjuvant- induced arthritis up-regulation of the vascular arginase pathway. Arthritis Rheum 2011; 63: 2309-2317.
9. Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, Donald AE, Palacios M, Griffin GE, Deanfield JE, MacAllister RJ, Vallance P: Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102: 994-999.
10. Ku IA, Imboden JB, Hsue PY, Ganz P: Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis. Circ J 2009; 73: 977-985.
11. Flammer AJ, Luscher TF: Three decades of endothelium research: from the detection of nitric oxide to the everyday implementation of endothelial function measurements in cardiovascular diseases. Swiss Med Wkly 2010; 140:w13122.
12. Kinlay S, Libby P, Ganz P: Endothelial function and coronary artery disease. Curr Opin Lipidol 2001; 12: 383-389.
13. Khan F, Galarraga B, Belch JJ: The role of endothelial function and its assessment in rheumatoid arthritis. Nat Rev Rheumatol 2010; 6: 253-261.
14. Luscher TF, Richard V, Tschudi M, Yang ZH, Boulanger C: Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol 1990; 15: 519-527.
15. Boulanger CM, Vanhoutte PM: G proteins and endothelium-dependent relaxations. J Vasc Res 1997; 34: 175-185.
16. Shimokawa H, Aarhus LL, Vanhoutte PM: Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res 1987; 61: 256-270.
17. Shibano T, Codina J, Birnbaumer L, Vanhoutte PM: Pertussis-toxin- sensitive G proteins in regenerated endothelial cells of porcine coronary artery. Am J Physiol 1994; 267:H979-H981.
18. Headrick JP, Peart JN, Reichelt ME, Haseler LJ: Adenosine and its receptors in the heart: regulation, retaliation and adaptation. Biochim Biophys Acta 2011; 1808: 1413-1428.
19. Mustafa SJ, Morrison RR, Teng B, Pelleg A: Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology; in Wilson CN, Mustafa SJ (eds): Adenosine Receptors in Health and Disease. Springer Berlin, 2009, vol 193, pp 161-188.
20. Flavahan NA, Shimokawa H, Vanhoutte PM: Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J Physiol 1989; 408: 549-560.
21. Vanhoutte PM, Houston DS: Platelets, endothelium, and vasospasm. Circulation 1985; 72: 728-734.
22. Bendele AM: Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 2001; 1: 377-385.
23. Pearson CM: Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med 1956; 91: 95-101.
24. Brackertz D, Mitchell GF, Mackay IR: Antigen- induced arthritis in mice. 1. Induction of arthritis in various strains of mice. Arthritis Rheum 1977; 20: 841-850.
25. Cromartie WJ, Craddock JG, Schwab JH, Anderle SK, Yang CH: Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med 1977; 146: 1585-1602.
26. Trentham DE, Townes AS, Kang AH: Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977; 146: 857-868.
27. Carlson RP, Datko LJ, Oneilldavis L, Blazek EM, Delustro F, Beideman R, Lewis AJ: Comparison of inflammatory changes in established type-II collagen-induced and adjuvantinduced arthritis using outbred Wistar rats. Int J Immunopharmacol 1985; 7: 811-826.
28. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE: The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007; 56: 3583-3587.
29. Stamatelopoulos KS, Kitas GD, Papamichael CM, Chryssohoou E, Kyrkou K, Georgiopoulos G, Protogerou A, Panoulas VF, Sandoo A, Tentolouris N, Mavrikakis M, Sfikakis PP: Atherosclerosis in rheumatoid arthritis versus diabetes a comparative study. Arterioscler Thromb Vasc Biol 2009; 29: 1702-1708.
30. Can C, Cinar MG, Kosay S, Evinc A: Vascular endothelial dysfunction associated with elevated serum homocysteine levels in rat adjuvant arthritis: effect of vitamin E administration. Life Sci 2002; 71: 401-410.
31. Egan CG, Lockhart JC, Ferrell WR: Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation. J Physiol 2004; 557: 635-643.
32. Sakuta T, Morita Y, Satoh M, Fox DA, Kashihara N: Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis effect of angiotensin receptor blockers. Arthritis Rheum 2010; 62: 1319-1328.
33. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu WH, Richards DR, Mc-Donald-Smith GP, Gao H, Hennessy L, Finnerty CC, Lopez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao WZ, Tompkins RG, Inflammation and Host Response to Injury, Large Scale Collaborative Research Program: Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013; 110: 3507-3512.
34. Scheerlinck JPY, Snibson KJ, Bowles VM, Sutton P: Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol 2008; 26: 259-266.
35. Thorp BH, Kimpton WG, Washington EA, Morrow CJ, Rowley MJ: Type II collagen-immune complex arthritis in sheep: collagen antibodies in serum, synovial fluid and afferent lymph. Clin Exp Rheumatol 1992; 10: 143-150.
36. Fraser JR, Kimpton WG, Pierscionek BK, Cahill RN: The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. Semin Arthritis Rheum 1993; 22: 9-17.
37. Goodson N, Marks J, Lunt M, Symmons D: Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 2005; 64: 1595-1601.
38. Ulker S, Onal A, Hatip FB, Surucu A, Alkanat M, Kosay S, Evinc A: Effect of nabumetone treatment on vascular responses of the thoracic aorta in rat experimental arthritis. Pharmacology 2000; 60: 136-142.
39. Shimokawa H, Flavahan NA, Vanhoutte PM: Natural course of the impairment of endothelium- dependent relaxations after balloon endothelium removal in porcine coronary arteries - possible dysfunction of a pertussis toxinsensitive G protein. Circ Res 1989; 65: 740-753.
40. Schachinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
41. Pelc LR, Gross GJ, Warltier DC: Mechanism of coronary vasodilation produced by bradykinin. Circulation 1991; 83: 2048-2056.
42. Liao JK, Homcy CJ: The G proteins of the G alpha i and G alpha q family coupled the bradykinin receptor to the release of endothelium- derived relaxing factor. J Clin Invest 1993; 92: 2168-2172.
43. McLean PG, Perretti M, Ahluwalia A: Kinin B(1) receptors and the cardiovascular system: regulation of expression and function. Cardiovasc Res 2000; 48: 194-210.
44. Villalon CM, Centurion D: Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors/ mechanisms involved and therapeutic implications. Naunyn Schmiedebergs Arch Pharmacol 2007; 376: 45-63.
45. Flavahan NA, Vanhoutte PM: G-proteins and endothelial responses. Blood Vessels 1990; 27: 218-229.
46. Maki-Petaja KM, Cheriyan J, Booth AD, Hall FC, Brown J, Wallace SML, Ashby MJ, Mc-Eniery CM, Wilkinson IB: Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction. Int J Cardiol 2008; 129: 399-405.
47. Bertolet BD, Hill JA: Adenosine - diagnostic and therapeutic uses in cardiovascular medicine. Chest 1993; 104: 1860-1871.
48. Olanrewaju HA, Gafurov BS, Lieberman EM: Involvement of K + channels in adenosine A2A and A2B receptor-mediated hyperpolarization of porcine coronary artery endothelial cells. J Cardiovasc Pharmacol 2002; 40: 43-49.
49. Teng BY, Qin WX, Ansari HR, Mustafa SJ: Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery. Am J Physiol Heart Circ Physiol 2005; 288:H2574-H2580.
50. Olanrewaju HA, Hargittai PT, Lieberman EA, Mustafa SJ: Role of endothelium in hyperpolarization of coronary smooth-muscle by adenosine and its analogs. J Cardiovasc Pharmacol 1995; 25: 234-239.
51. Turesson C, Matteson EL: Vasculitis in rheumatoid arthritis. Curr Opin Rheumatol 2009; 21: 35-40.
52. Flammer AJ, Luscher TF: Human endothelial dysfunction: EDRFs. Pflugers Arch 2010; 459: 1005-1013.
53. Kunapuli SP, Daniel JL: P2 receptor subtypes in the cardiovascular system. Biochem J 1998; 336: 513-523.
54. Bolton TB, Clapp LH: Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle. Br J Pharmacol 1986; 87: 713-723.
55. Attina TM, Oliver JJ, Malatino LS, Webb DJ: Contribution of the M3 muscarinic receptors to the vasodilator response to acetylcholine in the human forearm vascular bed. Br J Clin Pharmacol 2008; 66: 300-303.